ELK1 and urinary bladder cancer: An earlier report showed that silodosin was able to produce pro-apoptotic activity in bladder cancer cells by enhancing the cytotoxic activity of cisplatin via ELK1 inactivation.35 Silodosin is produced by α-androgenic blockers.